Protective Effects of Diltiazem and the Prostazycline Analogue Iloprost in Human Renal Transplantation

References

• Weir M R, Peppier R, Gomolka D, Handwerger BS. Additive effect of cyclosporine and verapamil amy occur through different mechanisms taht may be dependent or independent on the slow calcium channel. Transplant Proc 1989; 21: 866–870
   PubMed Web of Science ®Google Scholar
• Scholz D, Horpascy G, Mebel M. Late prognosis in acute post-transplant renal failure in 102 patients. Eur Urol 1979; 5: 14–17
   Google Scholar
• Miwa H, Von-Loenen M, Van der werf BA. The long-term effect of delayed graft function on cadaveric renal transplants treated with low-dose cyclosporine. Clin Transplantation 1989; 275–280
   Google Scholar
• Neumayer H H, Henkel M, Wagner K. Cyclosporine immunosuppression and early kidney graft function. Transplant Proc 1988; 20: 226–232
   Google Scholar
• Agatstein E R, Farrer J H, Kaplan LM. The effect of verapamil in reducing the severity of acute tubular necrosis in canine renal autotransplants. Transplantation 1987; 44: 335–357
   PubMedGoogle Scholar
• Duggan K A, MacDonald G J, Charlesworth J A, Pussel BA. Verapamil prevents posttransplant oliguric renal failure. Clin Nephrol 1988; 24: 289–291
   Google Scholar
• Neumayer H H, Wagner K. Calciumantagonisten und Gewebeprotektion. Intensivmed 1987; 24: 149–162
   Google Scholar
• Neumayer H H, Wagner K. Prevention of delayed graft function in cadaver kidney transplants by diltiazem: Outcome of two prospective randomized clinical trials. J Cardiovasc Pharmacol 1987; 10: S170–S177
   Google Scholar
• Neumayer H H, Schreiber M, Wagner K. Prevention of delayed graft function by diltiazem and iloprost. Transplant Proc 1989; 21: 1221–1224
   Google Scholar
• Christians U, Zimmer K O, Wonigeit K, Sewing KF. Measurement of cyclosporin A and of four metabolites in whole blood by high performance liquid chromtography. J Chromatogr 1987; 413: 121–129
   PubMed Web of Science ®Google Scholar
• Kunzendorf U, Walz G, Brockmoller J, Neumayer H H, Jochimsen F, Roots I, Offermann G, Strom TB. Effects of diltiazem on metabolism and immunosuppressive action of cyclosporine in kidney graft recipients. Transplantation., In press
   Google Scholar
• Hall J E, Guyton A C, Farr BM. A single-injection method for measuring glomerular filtration rate. Am J Physiol 1977; 232: F72–F76
   PubMed Web of Science ®Google Scholar
• Robert A. Antisecretory, antiulcer, cytoprotective and diarrheogenic properties of prostaglandins. Adv Prostaglandin Thromboxane Leukotriene Res, Paoletti Samuelsson, 1976; 2: 507–520
   Google Scholar
• Moran M, Mozes M F, Maddux M, Veremis S, Bartkus C, Ketel B, Pollak R, Wallemark C, Jonasson O. Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal transplant recipients treated with cyclosporine and prednisone. N Engl J Med 1990; 322: 1183–1188
   PubMed Web of Science ®Google Scholar
• Meyers B D, Ross J, Newton L. Cyclosporine-associated chronic nephropathy. N Engl J Med 1984; 311: 699–705
   Google Scholar
• Mihatsch M F, Ryffel B, Hermle M, Brunner F P, Thiel G. Morphology of cyclosporine nephrotoxicity in the rat. Clin Nephrol 1986; 25: S2
   PubMed Web of Science ®Google Scholar
• Myers D B, Sibley R, Newton L, Tomlanowich S T, Boshkos C, Stinson E, Luetscher J A, Whitney D J, Krasny D, Coplon N S, Perlroth MG. The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int 1988; 33: 590–600
   PubMed Web of Science ®Google Scholar
• Loutzenhiser R, Epstein M. Renal microvascular actions of calcium antagonists. J Am Soc Nephrol 1990; 1: S3–S12
   Google Scholar
• Curtis J J, Luke R G, Dubowsky E, Diethelm A G, Welchel J D, Jones P. Cyclosporine in therapeutic doses increases renal allograft resistance. Lancet 1986; 2: 477–491
   PubMed Web of Science ®Google Scholar
• Barros E JG, Boim M A, Ajzen H, Ramos O L, Schor N. Glomerular hemodynamics and hormonal participation in cyclosporine nephrotoxicity. Kidney Int 1987; 32: 19–25
   PubMed Web of Science ®Google Scholar
• Weir M R, Klassen D K, Shen S Y, Sullivan D, Buddemeyer EU. Handwerker BS: Acute effects of intravenous cyclosporine on blood pressure, renal hemodynamics and urine prostaglandin production of healthy humans. Transplantation 1990; 49: 41–47
   PubMed Web of Science ®Google Scholar
• Walz G, Kunzendorf U, Keller F, Neumayer H H, Offermann G. Cyclosporine blood levels in diltiazem treated kidney graft recipients. Clin Transplant 1988; 2: 21–25
   Google Scholar
• Wagner K, Philipp T H, Heinemeyer G, Brockmöller R, Roots I, Neumayer HH. Interaction of cyclosporine and calcium antagonists. Transplant Proc 1989; 21: 1453–1456
   Google Scholar
• Brockmoller J, Neumayer H H, Wagner K, Weber W, Heinemeyer G, Kewitz H, Roots I. Pharmacokinetic interaction between cyclosporin and diltiazem. Eur J Clin Pharmacol 1990; 38: 237–242
   PubMed Web of Science ®Google Scholar
• Dawidson I, Rooth P, Fry W R, Coorpender L, Reisch J. Verapamil ameliorates cyclosporine A nephrotoxicity and improves immunosuppression after cadaver renal transplantation. Transplant Proc 1988; 20: 222–224
   Google Scholar
• Cantarovich M, Hiesse C, Lockier F, Charpentier B, Fries D. Confirmation of the interaction between cyclosporine and the calcium channel blocker nicardipine. Clin Nephrol 1987; 28: 190–193
   Google Scholar
• Wagner K, Henkel M, Heinemeyer G, Neumayer HH. Interaction of calcium blockers and cyclosporine. Transplant Proc 1988; 20: 561–568
   Google Scholar
• Neumayer H H, Wagner K. Diltiazem and the economic use of cyclosporine. Lancet 1986; II: 523
   Google Scholar
• Kunzendorf U, Brockmöller J, Jochimsen F, Roots I, Offermann G. Immunosuppressive properties of cyclosporine metabolites. Lancet 1989; 1: 734–735
   Google Scholar